Tetranectin has been investigated as a biomarker; it is down regulated in metastatic cancer like lymph node cancer, oral cancer, colonic cancer, ovarian cancer and breast cancer [21, 22]. The gene discussed is CLEC3B; the disease is ovarian carcinoma.